Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive propertiesThomas L. Bonneaud, Frédérique Souazé|Cell Death and Disease|2022Cited by 20
Low BCL-xL expression in triple-negative breast cancer cells favors chemotherapy efficacy, and this effect is limited by cancer-associated fibroblastsLisa Nocquet, Frédérique Souazé|Scientific Reports|2024Cited by 15
Targeting of MCL-1 in breast cancer associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive propertiesTL Bonneaud, Frédérique Souazé|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 1
Cancer associated fibroblasts mitigate the efficacy of the combination of chemotherapy and BCL-xL targeting in triple negative breast cancer cellsLisa Nocquet, Frédérique Souazé|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 1
Cancer associated fibroblasts mitigate the efficacy of the combination of chemotherapy and BCL-xL targeting in triple negative breast cancer cellsFrédérique Souazé, Philippe Juin|Research Square|2024Cited by 0